USAR Gains 62.7% in the Past Year: Buy, Sell or Hold the Stock?

Core Insights - USA Rare Earth, Inc. (USAR) shares have increased by 62.7% over the past year, outperforming the industry and the S&P 500, which returned 48.7% and 25.2% respectively [1] - The company's peers, NioCorp Developments Ltd. and MP Materials, have seen gains of 166.9% and 151.1% respectively during the same period [1] Stock Performance - USAR closed at $18.71, below its 52-week high of $43.98 and above its 52-week low of $5.56 [4] - The stock is trading above its 200-day moving average but below its 50-day moving average, indicating a strong long-term trend despite some near-term softness [4] Operational Developments - USAR is set to commission its Stillwater NdFeB magnet plant in early 2026, with a capacity expansion to approximately 1,200 metric tons funded by a $1.5 billion PIPE financing [6][10] - The company has acquired Texas Mineral Resources to gain full control of the Round Top Project, expecting commercial production to begin in 2028 [11] Strategic Initiatives - The Stillwater facility is designed to produce Neodymium Iron Boron (NdFeB) magnets, crucial for various high-growth applications [8] - USAR is hiring and training engineers and technicians to prepare for commercial-scale production, which is expected to help secure long-term customer contracts [9] Financial Position - USAR's selling, general, and administrative expenses rose significantly to $11.4 million in Q3 2025 from $0.8 million in the previous year, driven by increased legal, consulting, and recruitment costs [14] - Research and development expenses also increased to $4.45 million compared to $1.16 million in the year-ago quarter [16] Valuation Metrics - The company is trading at a forward price-to-earnings ratio of negative 58.75X, compared to the industry average of 14.43X [19] Future Outlook - USAR is advancing its Stillwater magnet facility and expanding its rare earth supply chain, but it remains pre-revenue and continues to incur losses due to rising operational and R&D expenses [20]